Reimagine Care
Reimagine Care gives cancer patients a text based assistant and oncology trained nurses available around the clock, so side effects can be handled at home instead of in an emergency department. It was bought by the French company Cureety in 2026.
Overview
Reimagine Care operates a virtual care centre for oncology practices and health systems. Patients report symptoms conversationally to Remi, an oncology specific AI assistant, with escalation to oncology trained clinicians available 24/7; partners include Memorial Hermann and Moffitt Cancer Center. The company reports that 97 to 98 percent of symptom interactions are resolved without the patient leaving home, 93 percent without escalation to the partner provider, and 30 percent fewer avoidable emergency department visits than national benchmarks. Based in Nashville, Reimagine Care raised a USD 25 million Series A in January 2022 co-led by Santé Ventures, Martin Ventures and LRVHealth, with City of Hope and McKesson Ventures participating. In September 2026 it was acquired by Cureety, a Paris based oncology remote monitoring company; the combined group states it supports more than 250 cancer centres and 100,000 patients in five countries.
Funding
All startups| Round | Year | Amount | Source |
|---|---|---|---|
| Acquisition · Acquired by Cureety (Paris) in September 2026; financial terms not disclosed | 2026 | undisclosed | reimaginecare.com |
| Series A · Co-led by Santé Ventures, Martin Ventures and LRVHealth | 2022 | $25M | reimaginecare.com |
Amounts only where the cited source states them. Rounds without a public source are not listed.
Notes
top- Founding year not stated in any fetched source. Memorial Hermann and Oncology Ventures investments are listed on the company publications index but the amounts were not fetched, so they are not recorded as rounds.